- API
Case Mix Index
healthdata.gov | Last Updated 2023-10-03T04:00:18.000ZThe Case Mix Index (CMI) is the average relative DRG weight of a hospital’s inpatient discharges, calculated by summing the Medicare Severity-Diagnosis Related Group (MS-DRG) weight for each discharge and dividing the total by the number of discharges. The CMI reflects the diversity, clinical complexity, and resource needs of all the patients in the hospital. A higher CMI indicates a more complex and resource-intensive case load. Although the MS-DRG weights, provided by the Centers for Medicare & Medicaid Services (CMS), were designed for the Medicare population, they are applied here to all discharges regardless of payer. Note: It is not meaningful to add the CMI values together.
- API
Adverse Event Reporting System (AERS)
healthdata.gov | Last Updated 2023-07-25T18:45:34.000ZThe Adverse Event Reporting System (AERS) is a computerized information database designed to support the FDA's post-marketing safety surveillance program for all approved drug and therapeutic biologic products. The FDA uses AERS to monitor for new adverse events and medication errors that might occur with these marketed products. Reporting of adverse events from the point of care is voluntary in the United States. FDA receives some adverse event and medication error reports directly from health care professionals (such as physicians, pharmacists, nurses and others) and consumers (such as patients, family members, lawyers and others). Healthcare professionals and consumers may also report these events to the products' manufacturers. If a manufacturer receives an adverse event report, it is required to send the report to FDA as specified by regulations. The files listed on this page contain raw data extracted from the AERS database for the indicated time ranges and are not cumulative. Users of these files need to be familiar with creation of relational databases using applications such as ORACLE, Microsoft Office Access, MySQL and IBM DB2 or the use of ASCII files with SAS analytic tools. A simple search of AERS data cannot be performed with these files by persons who are not familiar with creation of relational databases.
- API
Prescription Drug Wholesale Acquisition Cost (WAC) Increases
healthdata.gov | Last Updated 2024-06-11T04:00:16.000ZThis dataset is comprised of data submitted to HCAI by prescription drug manufacturers for wholesale acquisition cost (WAC) increases that exceed the statutorily-mandated WAC increase threshold of an increase of more than 16% above the WAC of the drug product on December 31 of the calendar year three years prior to the current calendar year. This threshold applies to prescription drug products with a WAC greater than $40 for a course of therapy. Required WAC increase reports are to be submitted to HCAI within a month after the end of the quarter in which the WAC increase went into effect. Please see the statute and regulations for additional information regarding reporting thresholds and report due dates. Key data elements in this dataset include the National Drug Code (NDC) maintained by the FDA, narrative descriptions of the reasons for the increase in WAC, and the five-year history of WAC increases for the NDC. A WAC Increase Report consists of 27 data elements that have been divided into two separate Excel data sets: Prescription Drug WAC Increase and Prescription Drug WAC Increase – 5 Year History. The datasets include manufacturer WAC Increase Reports received since January 1, 2019. The Prescription Drugs WAC Increase dataset consists of the information submitted by prescription drug manufacturers that pertains to the current WAC increase of a given report, including the amount of the current increase, the WAC after increase, and the effective date of the increase. The Prescription Drugs WAC Increase – 5 Year History dataset consists of the information submitted by prescription drug manufacturers for the data elements that comprise the 5-year history of WAC increases of a given report, including the amount of each increase and their effective dates. There are 2 types of WAC Increase datasets below: Monthly and Annual. The Monthly datasets include the data in completed reports submitted by manufacturers for calendar year 2024, as of June 10, 2024. The Annual datasets include data in completed reports submitted by manufacturers for the specified year. The datasets may include reports that do not meet the specified minimum thresholds for reporting. The Quick Guide explaining how to link the information in each data set to form complete reports is here: https://hcai.ca.gov/wp-content/uploads/2024/03/QuickGuide_LinkingTheDatasets.pdf The program regulations are available here: https://hcai.ca.gov/wp-content/uploads/2024/03/CTRx-Regulations-Text.pdf The data format and file specifications are available here: https://hcai.ca.gov/wp-content/uploads/2024/03/Format-and-File-Specifications-version-2.0-ada.pdf DATA NOTES: Due to recent changes in Excel, it is not recommended that you save these files to .csv format. If you do, when importing back into Excel the leading zeros in the NDC number column will be dropped. If you need to save it into a different format other than .xlsx it must be .txt DATA UPDATES: Annual datasets of reports from the preceding year are reviewed in the second half of the current year to identify if any revisions or additions have been made since the original release of the datasets. If revisions or additions have been found, an update of the datasets will be released. Datasets will be clearly marked with 'Updated' in their titles for convenient identification. Not all datasets may require an updated release. The review of previously released datasets will only be conducted once to determine if an updated release is necessary. Datasets with revisions or additions that may have been made after the one-time review can be requested. These requests should be sent via email to ctrx@hcai.ca.gov. Due to regulatory changes that went into effect April 1, 2024, reports submitted prior to April 1, 2024, will include Unit Sales Volume in US and reports submitted on or after April 1, 2024, will instead include Total Volume of Gross Sales in US Dollars.
- API
National Database for Autism Research (NDAR)
healthdata.gov | Last Updated 2023-07-26T01:20:02.000Z<p>National Database for Autism Research (NDAR) is an extensible, scalable informatics platform for autism spectrum disorder-relevant data at all levels of biological and behavioral organization (molecules, genes, neural tissue, behavioral, social and environmental interactions) and for all data types (text, numeric, image, time series, etc.). NDAR was developed to share data across the entire ASD field and to facilitate collaboration across laboratories, as well as interconnectivity with other informatics platforms.</p> <p> NDAR Homepage: http://ndar.nih.gov/</p>
- API
DailyMed
healthdata.gov | Last Updated 2024-06-21T04:01:41.000ZDailyMed provides high quality information about marketed drugs. This information includes FDA labels (package inserts). This Web site provides health information providers and the public with a standard, comprehensive, up-to-date, look-up and download resource of medication content and labeling as found in medication package inserts. The National Library of Medicine (NLM) provides this as a public service and does not accept advertisements.
- API
Food-a-pedia
healthdata.gov | Last Updated 2023-07-25T17:52:01.000ZFind the calorie content of any food or beverage using the Food-a-pedia, looking at the Nutrition Facts label, or checking product or restaurant websites
- API
Provisional COVID-19 Death Counts by Age in Years, 2020-2023
healthdata.gov | Last Updated 2023-07-25T18:39:32.000ZEffective June 28, 2023, this dataset will no longer be updated. Similar data are accessible from CDC WONDER (https://wonder.cdc.gov/mcd-icd10-provisional.html). Cumulative deaths involving COVID-19 reported to NCHS by sex and age in years, in the United States.
- API
MAUDE (Manufacturer and User Facility Device Experience)
healthdata.gov | Last Updated 2023-07-26T01:24:59.000ZMAUDE data represents reports of adverse events involving medical devices. The data consists of all voluntary reports since June, 1993, user facility reports since 1991, distributor reports since 1993, and manufacturer reports since August, 1996.
- API
Rates of COVID-19 Cases or Deaths by Age Group and Vaccination Status and Booster Dose
healthdata.gov | Last Updated 2023-07-25T18:28:42.000ZData for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022. Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases
- API
MeSH on Demand
healthdata.gov | Last Updated 2023-07-25T18:54:15.000ZMeSH on Demand identifies MeSH Terms in your text using the NLM Medical Text Indexer (MTI) program. After processing, MeSH on Demand returns a list of MeSH Terms relevant to your text as well as a list of related articles from PubMed.